Trials / Completed

CompletedNCT03157050

Intravenous Iron May Increase Depression Among Hemodialysis Patients

Status: Completed
Phase: —
Study type: Observational
Enrollment: 112 (actual)

Sponsor: Benha University · Academic / Other
Sex: All
Age: 19 Years
Healthy volunteers: Not accepted

Summary

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Conditions

Depression
Hemodialysis Complication
Iron Deficiency Anemia

Interventions

Type	Name	Description
OTHER	Intravenous iron therapy	each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses

Timeline

Start date: 2016-01-14
Primary completion: 2017-05-15
Completion: 2017-05-16
First posted: 2017-05-17
Last updated: 2017-05-17

Source: ClinicalTrials.gov record NCT03157050. Inclusion in this directory is not an endorsement.